The levels of GDNF in PSP, revealed in the study, may suggest a possibly protective role of this factor in a more deteriorating form of the disease, as GDNF release may be activated as a contrary mechanism to accelerated neurodegeneration in PSP-RS. The gene discussed is GDNF; the disease is supranuclear palsy, progressive, 1.